This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Time and frequency to observe fiducial markers in MLC-modulated fields during prostate IMRT/VMAT beam delivery
Phys Med. 2020 Jul 14;76 :142-149
PMID: 32679409 PMCID: PMC7528608 URL: https://www.ncbi.nlm.nih.gov/pubmed/32679409
AbstractOBJECTIVE: This work investigates the time and frequency to observe fiducial markers in MLC-modulated fields during intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) beam delivery for real-time prostate localization. METHODS: Thirty seven prostate patients treated with IMRT or VMAT were included in this retrospective study. DRR images were generated for all MLC segments/control points using the TPS. The MLC leaf pattern of each control point was overlaid on the DRR, and the number of fiducials within the MLC opening was analyzed. EPID images of fiducials in a pelvic phantom were obtained to demonstrate the fiducial visibility during modulated beam delivery. RESULTS: Gold fiducials were visible on EPID images. The probability of seeing a number of fiducials within the MLC opening was analyzed. At least one fiducial was visible during 42 ± 2% and 52 ± 2% beam-on time for IMRT of the prostate with and without lymph nodes, and during 81 ± 4% and 80 ± 5% beam-on time for VMAT of the prostate with and without lymph nodes, respectively. The mean time interval to observe at least one fiducial was 8.4 ± 0.7 and 5.9 ± 0.5 s for IMRT of the prostate with and without the lymph nodes, respectively, and 1.6 ± 0.1 s for VMAT prostate patients. The estimated potential dosimetric uncertainty was 7% and 2% for IMRT and VMAT, respectively. CONCLUSIONS: Our results demonstrated that the time and frequency to observe fiducial markers in MLC-modulated fields during IMRT/VMAT beam delivery were adequate for real-time prostate localization. The beam's eye view fiducial positions could be used for intrafractional target monitoring and motion correction in prostate radiotherapy.
Notes1724-191x Xu, Qianqian Tong, Xu Lin, Muhan Chen, Xiaoming ElDib, Ahmed Lin, Teh Chen, Lili Ma, C-M Charlie Journal Article Italy Phys Med. 2020 Jul 14;76:142-149. doi: 10.1016/j.ejmp.2020.06.026.